Munger Mode rating: 3 out of 5 — Hold. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Charlie and I put Gilead in the first kind of Hold. This is a very good business, with a franchise that earns outsized returns and management that is competent and shareholder-friendly. The price is now ahead of what we can defend as intrinsic value. We would not call it a wonderful business in the sense of a moat that compounds for decades. Its moat is a patent-and-regulatory moat, which is real but has a finite life, and it sits on a single dominant product. The stock has risen from about $124 in June to about $171 after a strong third quarter. At roughly 19 times normalized earnings, we are paying for the franchise to last longer than we can verify. If you own it, we would hold it and collect the dividend. We would not initiate a new position here. Below about $135 we would want to buy. A note on sources. The financial statements come from the Q3 2026 10-Q you provided.
Recent filings analysed: 10-Q (2026-10-30), 8-K (2026-10-29), 10-Q (2026-08-06), 8-K (2026-08-04).
Stock screener · Superinvestor 13F holdings · Analyst sentiment